SEC Form 4 · accession 0001325812-15-000025
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward M. Kaye M.D.
Officer — SVP Interim CEO & CMO
Period of report
Apr 20, 2015
Accepted (ET)
Apr 22, 2015 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2015 | A | 110,783 | $0.00 | A | 112,094 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This restricted stock award will vest in twelve substantially equal quarterly installments on each three-month anniversary of April 20, 2015.